Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer

PURPOSE: Triple negative breast cancers (TNBC) frequently have high epidermal growth factor receptor (EGFR) expression and are sensitive to DNA-damaging agents. Improved therapies are needed for this aggressive malignancy. PATIENTS AND METHODS: We performed a phase I trial of bendamustine and erloti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Layman, Rachel M., Ruppert, Amy S., Lynn, Melinda, Mrozek, Ewa, Ramaswamy, Bhuvaneswari, Lustberg, Maryam B., Wesolowski, Robert, Ottman, Susan, Carothers, Sarah, Bingman, Anissa, Reinbolt, Raquel, Kraut, Eric H., Shapiro, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3710373/
https://ncbi.nlm.nih.gov/pubmed/23430121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2112-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados